Struggling from Generalized Anxiety Disorder (GAD)?
You may be able to join our research study of an investigational drug for the treatment of Generalized Anxiety Disorder (GAD).
See If You Qualify
- No cost to check eligibility
- No obligation to participate
- A coordinator confirms eligibility by phone
- You can withdraw at any time
This pre-screening does not guarantee enrollment.
Overview
Have you tried prescribed medication but are still experiencing unwanted anxiety symptoms? If so, you may be able to join our research study of an investigational drug for the treatment of Generalized Anxiety Disorder (GAD).
Anxiety Study Now Enrolling
Join our research study of an investigational drug for anxiety symptoms from GAD.
About the Study
We understand the challenges that come with living with generalized anxiety disorder (GAD). While occasional anxiety is a normal part of life, having GAD means that your anxiety is out of control or negatively impacting your day-to-day life.
Doctors have several prescription treatment options for GAD. Antidepressants are often used as the first treatment for the symptoms of GAD. Buspirone has also been approved for the treatment of GAD. However, in some people, these treatments may not be providing enough relief from excessive worry and other GAD symptoms.
This is why there is a need for new treatment options for GAD. Since so many people’s symptoms may not respond to these currently available treatments, there is still a need for other therapies that are safe and effective.
This research study will evaluate an investigational drug to be taken for GAD in individuals who have taken at least two prescription GAD treatments with unsatisfactory symptom relief.
Before new medications can be approved for public use, they must be tested in research studies like this one. If you have tried treating your GAD with at least two prescribed medications that did not provide enough symptom relief, please continue reading to see if our study may be of interest to you
Benefits
Compensation
Many studies include compensation for time and travel
Study-Related Care
Study-related medication and care provided at no cost
No Insurance Needed
Insurance is not needed to participate in this study.
Who Can Join
To join this study, potential study participants:
Must be at least 18 years of age
Must have taken treatments for GAD without adequate symptom relief
Have a primary diagnosis of Generalized Anxiety Disorder (GAD)
This is not a complete list of study requirements. The staff at the study center will explain the complete list of requirements
What to Expect
Consent
Before a potential participant decides to proceed in this study, the study staff will review with them the informed consent form to provide a detailed explanation of this study and its potential risks and benefits, along with their rights as a participant.
Screening
During screening, the study staff reviews medical history and conducts a series of study-related examinations, assessments, and laboratory tests to see if the study requirements are met.
Treatment
Participants will take their assigned study drug once a day for the duration of the Treatment Period.
Follow-Up
One week after the last dose of study drug, participants will return to the study center for a safety follow-up.
Participating Locations
Know Someone Who Might Qualify?
Share this study with a friend or family member who may benefit.